News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
New Leaf Ventures III, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/27/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| New Leaf Ventures III, L.P. reports a 9.8% stake in Harpoon Therapeutics, Inc. |
| 02/11/2022 |
SC 13G
| New Leaf Ventures III, L.P. reports a 7.2% stake in Rallybio Corporation |
| 02/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/11/2022 |
SC 13G/A
| New Leaf Ventures III, L.P. reports a 2.4% stake in Arvinas, Inc. |
| 08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 11/15/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/19/2019 |
4
| New Leaf Venture Management III, L.L.C. (10% Owner) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 71,550 shares
@ $36.0911, valued at
$2.6M
Sold 69,292 shares
@ $36.5433, valued at
$2.5M
Sold 26,108 shares
@ $37.0148, valued at
$966.4k
Sold 78,450 shares
@ $36.0911, valued at
$2.8M
Sold 75,974 shares
@ $36.5433, valued at
$2.8M
Sold 28,626 shares
@ $37.0148, valued at
$1.1M
|
|
| 03/25/2019 |
SC 13D/A
| New Leaf Ventures III, L.P. reports a 2.2% stake in PDS Biotechnology Corporation |
| 02/21/2019 |
SC 13G
| New Leaf Ventures III, L.P. reports a 12.2% stake in Harpoon Therapeutics, Inc. |
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2019 |
SC 13G
| New Leaf Ventures III, L.P. reports a 6% stake in Unum Therapeutics Inc. |
| 02/07/2019 |
3
| New Leaf Ventures III, L.P. (10% Owner) has filed a Form 3 on Harpoon Therapeutics, Inc. |
| 10/10/2018 |
SC 13G
| New Leaf Ventures III, L.P. reports a 7.1% stake in Arvinas, Inc. |
| 09/26/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/03/2018 |
SC 13D
| New Leaf Ventures III, L.P. reports a 9.8% stake in APTINYX INC. |
| 06/26/2018 |
4
| New Leaf Venture Management III, L.L.C. (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Converted 1,047,450 shares
@ $0
Converted 1,197,076 shares
@ $0
Converted 552,208 shares
@ $0
Converted 243,345 shares
@ $0
Bought 125,000 shares
@ $16, valued at
$2M
Bought 125,000 shares
@ $16, valued at
$2M
Converted 28,895,188 convertible preferred
@ $0
Converted 33,022,786 convertible preferred
@ $0
Converted 15,233,315 convertible preferred
@ $0
Converted 6,712,986 convertible preferred
@ $0 |
|
| 06/20/2018 |
3
| New Leaf Venture Management III, L.L.C. (10% Owner) has filed a Form 3 on Aptinyx Inc. |
| 05/24/2018 |
3
| New Leaf Venture Management III, L.L.C. (10% Owner) has filed a Form 3 on Iterum Therapeutics plc |
| 10/11/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 09/28/2017 |
3
| New Leaf Venture Management III, L.L.C. (10% Owner) has filed a Form 3 on Deciphera Pharmaceuticals, Inc. |
| 06/23/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 11/02/2015 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 10/13/2015 |
SC 13D
| New Leaf Ventures III, L.P. reports a 8.2% stake in Edge Therapeutics, Inc. |
|
|